soft tissue sarcoma

(redirected from Soft-tissue sarcoma)
Also found in: Wikipedia.

soft tissue sarcoma

Oncology A sarcoma that arises in muscle, fat, fibrous tissue, blood vessels, or other supporting tissues. See Sarcoma.
Soft tissue sarcoma staging
I A Tumor cells are morphologically similar to normal cells; tumor measures ≤ 5 cm
 B Ditto; tumor ≥ 5 cm
II A Tumor cells are mildly atypical; tumor measures ≤ 5 cm
 B Ditto; tumor ≥ 5 cm
III A Tumor cells are moderately or severely atypical/bizarre; tumor measures ≤ 5 cm
 B Ditto; tumor ≥ 5 cm
IV A Any cellular atypia; any sized tumor with lymph node involvement
 B Any cellular atypia; any sized tumor with metastasis  
References in periodicals archive ?
Skin cancer and soft-tissue sarcoma (STS) are among many types of cancer that can develop among any population worldwide.
Furthermore, Halaven has been designated as an orphan drug for soft-tissue sarcoma in the United States and Japan.
We conducted a retrospective review of pathology records of patients who underwent soft-tissue sarcoma excisions at CHBAH between January 2005 and December 2009.
Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry," J Surg Res.
Dermatofibrosarcoma was the second most prevalent soft-tissue sarcoma (56 patients; 18.
The trial is evaluating Zymafos, or palifosfamide, as a treatment for patients with unresectable or metastatic soft-tissue sarcoma.
KYOTO, JAPAN -- The incidence of Kaposi's sarcoma among American men jumped more than 30-fold in the 1980s with the AIDS epidemic, peaked around 1991, and then declined rapidly in concert with the introduction of highly active antiretroviral therapy, according to a study involving 12,114 cases of KS and other forms of cutaneous soft-tissue sarcoma.
Today, the list of presumptive service-connected health problems caused by exposure to Agent Orange and other herbicides includes chloracne (a skin disease), Hodgkin's disease, multiple mycloma to (a cancer of the blood cells), non-Hodgkin's lymphoma, porphyria cutanea tarda (a skin disease caused by a defective liver enzyme), respiratory cancers (lung, bronchus, larynx, and trachea), soft-tissue sarcoma (cancer of the muscles and tendons), acute and subacute peripheral neuropathy (weakening of the nervous system), prostate cancer, chronic lymphocytic leukemia, and adult-onset (Type 2) diabetes.
The seven are: chloracne, Hodgkin's disease, multiple myeloma, non-Hodgkin's lymphoma, porphyria cutanea tarda, respiratory cancers (of the lung, bronchus, larynx and trachea), and soft-tissue sarcoma.
Halaven has been designated as an orphan drug for the treatment of soft-tissue sarcoma in the United States and Japan.
Dioxins have been linked with Hodgkin disease, non-Hodgkin lymphoma, soft-tissue sarcoma, and more tentatively with type 2 diabetes mellitus and other conditions.